Clinical trial
Docetaxel in Treating Patients With Relapsed Prostate Cancer
NCT00482274
Study timeline
Study start (unknown)2007-05-01Date precision: month
Registry last updated2017-04-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
docetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
OHSU Knight Cancer Institutelead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00482274 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.